CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Significant Drop in Short Interest

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 16,900 shares, a decrease of 54.0% from the February 28th total of 36,700 shares. Based on an average trading volume of 107,500 shares, the short-interest ratio is currently 0.2 days.

CERo Therapeutics Stock Down 5.9 %

CERo Therapeutics stock traded down $0.00 during trading hours on Friday, reaching $0.01. 43,054 shares of the company were exchanged, compared to its average volume of 90,879. CERo Therapeutics has a 12 month low of $0.00 and a 12 month high of $0.13. The stock has a 50-day moving average of $0.01 and a 200 day moving average of $0.01.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.